Description: Quanmol Tech develops a molecular quantification platform that utilizes advanced analytical techniques to enhance chemical product design. This technology enables precise measurement of molecular properties, facilitating the development of more effective and tailored chemical solutions. Web Content:
Funding
Funding not disclosed


Founders
Product
Problem
Traditional methods of small molecule drug discovery are often slow and inefficient, requiring extensive experimental validation. Accurately predicting the properties and interactions of molecules with biomacromolecules remains a significant challenge.
Solution
QuanMol Tech has developed QuanMol ReDefine, an AI-powered in-silico molecular design platform that accelerates the discovery of novel small molecule therapeutics. The platform integrates physics-informed deep learning and computational chemistry to provide accurate predictions of molecular properties and protein-ligand interactions. QuanMol ReDefine enables researchers to design and optimize molecules with desired characteristics, streamlining the drug development process and reducing the need for extensive experimental screening. The platform offers a user-friendly interface, making advanced molecular design tools accessible to researchers and pharmaceutical companies.
Target Audience
The primary target audience includes pharmaceutical companies, drug discovery researchers, and computational chemists involved in the design and development of small molecule therapeutics.
Features
- QuanMol ReDefine platform integrating AI and computational chemistry for in-silico molecular design
- QuanMol Thinker: AI agent for rational molecular design, providing insights and decision-making capabilities
- QuanMol Unifier: Universal molecular representation platform for predicting pharmaceutical properties
- QuanMol Navigator: Structure prediction engine for protein-ligand interactions
- Physics-informed deep learning models for accurate property prediction
- User-friendly interface for researchers and pharmaceutical companies